Pharmacological Activities of Fingerroot Extract and Its Phytoconstituents Against SARS-CoV-2 Infection in Golden Syrian Hamsters

References

• World Health Organization. COVID-19 Clinical management: living guidance; 2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1. Accessed January 09, 2023.
   Google Scholar
• Centers for Disease Control and Prevention. Symptoms of COVID-19; 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html. Accessed January 9, 2023.
   Google Scholar
• Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J. 2020;55(4):2000607. doi:10.1183/13993003.00607-2020
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Therapeutic management of adults with COVID-19; 2021. Available from: https://www.covid19treatmentguidelines.nih.gov/therapeutic-management/. Accessed January 9, 2023.
   Google Scholar
• Department of Medical Services. Guidelines on clinical practice, diagnosis, treatment, and prevention of healthcare-associated infection for COVID-19; 2021. Available from: https://ddc.moph.go.th/viralpneumonia/eng/guideline_hcw.php. Accessed January 09, 2023.
   Google Scholar
• The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2020;384(8):693–704.
   PubMed Web of Science ®Google Scholar
• Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of COVID-19 — final report. N Engl J Med. 2020;383(19):1813–1826.
   PubMed Web of Science ®Google Scholar
• Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients. N Engl J Med. 2022;386(6):509–520.
   PubMed Web of Science ®Google Scholar
• Hammond J, Leister-Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19. N Engl J Med. 2022;386(15):1397–1408.
   PubMed Web of Science ®Google Scholar
• Vacharathit V, Aiewsakun P, Manopwisedjaroen S, et al. CoronaVac induces lower neutralising activity against variants of concern than natural infection. Lancet Infect Dis. 2021;21(10):1352–1354. doi:10.1016/S1473-3099(21)00568-5
   PubMed Web of Science ®Google Scholar
• Atanasov AG, Zotchev SB, Dirsch VM, et al. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200–216. doi:10.1038/s41573-020-00114-z
   PubMed Web of Science ®Google Scholar
• Sa-Ngiamsuntorn K, Suksatu A, Pewkliang Y, et al. Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives. J Nat Prod. 2021;84:1261–1270. doi:10.1021/acs.jnatprod.0c01324
   PubMed Web of Science ®Google Scholar
• Kanjanasirirat P, Suksatu A, Manopwisedjaroen S, et al. High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents. Sci Rep. 2020;10(1):19963. doi:10.1038/s41598-020-77003-3
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Imai M, Iwatsuki-Horimoto K, Hatta M, et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. PNAS. 2020;117(28):16587–16595. doi:10.1073/pnas.2009799117
   PubMed Web of Science ®Google Scholar
• Eng-Chong T, Yean-Kee L, Chin-Fei C, et al. Boesenbergia rotunda: from ethnomedicine to drug discovery. eCAM. 2012;2012:473637. doi:10.1155/2012/473637
   Google Scholar
• Ongwisespaiboon O, Jiraungkoorskul W. Fingerroot, Boesenbergia rotunda and its aphrodisiac activity. Pharmacogn Rev. 2017;11(21):27–30. doi:10.4103/phrev.phrev_50_16
   PubMedGoogle Scholar
• National Center for Biotechnology Information. PubChem compound summary for CID 6483648; 2021. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Panduratin-A. Accessed January 9, 2023.
   Google Scholar
• Cheenpracha S, Karalai C, Ponglimanont C, Subhadhirasakul S, Tewtrakul S. Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata. Bioorg Med Chem. 2006;14(6):1710–1714. doi:10.1016/j.bmc.2005.10.019
   PubMed Web of Science ®Google Scholar
• Yun J-M, Kwon H, Hwang J-K. In vitro anti-inflammatory activity of panduratin A isolated from Kaempferia pandurata in RAW264.7 cells. Planta Med. 2003;69(12):1102–1108.
   PubMed Web of Science ®Google Scholar
• Mohan S, Hobani YH, Shaheen E, et al. Ameliorative effect of Boesenbergin A, a chalcone isolated from Boesenbergia rotunda (Fingerroot) on oxidative stress and inflammation in ethanol-induced gastric ulcer in vivo. J Ethnopharmacol. 2020;261:113104. doi:10.1016/j.jep.2020.113104
   PubMed Web of Science ®Google Scholar
• Santa Cruz A, Mendes-Frias A, Oliveira AI, et al. Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia. Front Immunol. 2021;12:613422. doi:10.3389/fimmu.2021.613422
   PubMed Web of Science ®Google Scholar
• The Royal Thai Government Gazette. Announcement of the use to animals for scientific work committee: ethics of use to animals for scientific work; 2016:21–25.
   Google Scholar
• Talbot SR, Biernot S, Bleich A, et al. Defining body-weight reduction as a humane endpoint: a critical appraisal. Lab Anim. 2020;54(1):99–110. doi:10.1177/0023677219883319
   PubMedGoogle Scholar
• Tostanoski LH, Wegmann F, Martinot AJ, et al. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nat Med. 2020;26(11):1694–1700. doi:10.1038/s41591-020-1070-6
   PubMed Web of Science ®Google Scholar
• Kaptein SJF, Jacobs S, Langendries L, et al. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. PNAS. 2020;117(43):26955–26965. doi:10.1073/pnas.2014441117
   PubMed Web of Science ®Google Scholar
• Driouich J-S, Cochin M, Lingas G, et al. Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nat Commun. 2021;12(1):1735. doi:10.1038/s41467-021-21992-w
   PubMed Web of Science ®Google Scholar
• Pharmaceuticals and Medical Devices Agency. Review report of Avigan(favipiravir); 2014. Available from: https://www.pmda.go.jp/files/000210319.pdf. Accessed January 9, 2023.
   Google Scholar
• Saraithong P, Saenphet S, Saenphet K. Safety evaluation of ethanol extracts from Boesenbergia rotunda (L). Mansf. in male rats. Trends Res Sci Technol. 2010;2(1):19–22.
   Google Scholar
• Tewtrakul S, Subhadhirasakul S, Karalai C, Ponglimanont C, Cheenpracha S. Anti-inflammatory effects of compounds from Kaempferia parviflora and Boesenbergia pandurata. Food Chem. 2009;115(2):534–538. doi:10.1016/j.foodchem.2008.12.057
   Web of Science ®Google Scholar
• Rosenke K, Jarvis MA, Feldmann F, et al. Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models. JCI Insight. 2020;5(23):e143174. doi:10.1172/jci.insight.143174
   PubMed Web of Science ®Google Scholar
• Weston S, Coleman CM, Haupt R, et al. Broad anti-coronavirus activity of food and drug administration-approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo. J Virol. 2020;94(21):e01218–01220. doi:10.1128/JVI.01218-20
   PubMed Web of Science ®Google Scholar
• Sia SF, Yan LM, Chin AWH, et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583(7818):834–838. doi:10.1038/s41586-020-2342-5
   PubMed Web of Science ®Google Scholar
• Osterrieder N, Bertzbach LD, Dietert K, et al. Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters. Viruses. 2020;12(7):779. doi:10.3390/v12070779
   PubMed Web of Science ®Google Scholar
• Nouailles G, Wyler E, Pennitz P, et al. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. Nat Commun. 2021;12(1):4869. doi:10.1038/s41467-021-25030-7
   PubMed Web of Science ®Google Scholar
• Tian W, Zhang N, Jin R, et al. Immune suppression in the early stage of COVID-19 disease. Nat Commun. 2020;11(1):5859. doi:10.1038/s41467-020-19706-9
   PubMed Web of Science ®Google Scholar
• Samprathi M, Jayashree M. Biomarkers in COVID-19: an up-to-date review. Front Pediatr. 2021;8(972):607647. doi:10.3389/fped.2020.607647
   PubMedGoogle Scholar
• Francis ME, Goncin U, Kroeker A, et al. SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney. PLoS Pathog. 2021;17(7):e1009705. doi:10.1371/journal.ppat.1009705
   PubMed Web of Science ®Google Scholar
• Matveeva T, Khafizova G, Sokornova S. In search of herbal anti-SARS-CoV2 compounds. Front Plant Sci. 2020;11(1807):589998. doi:10.3389/fpls.2020.589998
   PubMedGoogle Scholar
• Murck H. Symptomatic protective action of glycyrrhizin (licorice) in COVID-19 infection? Front Immunol. 2020;11(1239):1239. doi:10.3389/fimmu.2020.01239
   PubMedGoogle Scholar
• Lim XY, Teh BP, Tan TYC. Medicinal plants in COVID-19: potential and limitations. Front Pharmacol. 2021;12(355):611408.
   PubMedGoogle Scholar
• Chan JF-W, Zhang AJ, Yuan S, et al. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis. 2020;71(9):2428–2446.
   PubMed Web of Science ®Google Scholar
• Ricke-Hoch M, Stelling E, Lasswitz L, et al. Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS One. 2021;16(8):e0255335.
   PubMed Web of Science ®Google Scholar
• Park Y-J, Acosta D, Vassell R, et al. D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes. PLoS Pathog. 2022;18(4):e1010468.
   PubMed Web of Science ®Google Scholar